Global Viral Vector Manufacturing Market to Reach US$ 3,162.5 Million by 2027, Bolstered by Increasing Number of Cancer Patients

February 15, 2022

The latest report by IMARC Group, titled “Viral Vector Manufacturing Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027,” finds that the global viral vector manufacturing market size reached US$ 746.6 Million in 2021. A viral vector is a tool used to deliver genetic material into cells. This process is performed inside a living organism (in vivo) or in cell culture (in vitro). It is widely used in gene and cell therapy to replace defective genes with functional genes. Besides this, viral vectors are also utilized to treat different diseases, such as heart defects, metabolic diseases, neurodegenerative disorders, and oncolytic therapies, to target and kill tumor cells. In recent years, there has been a significant rise in viral vector manufacturing due to the rising prevalence of genetic disorders.

We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.??

Global Viral Vector Manufacturing Market Trends:

The market is primarily driven by the rising number of cancer patients across the globe as viral vectors are used in suicide gene therapy, oncolytic virotherapy, anti-angiogenesis, and therapeutic gene vaccines to treat a wide range of cancers. In addition, the increasing number of clinical studies undertaken on viral vectors is contributing to the market growth. Besides this, as viral vectors are efficient carriers of virus-disabling sequences, they are widely used to deliver HIV-inhibiting transgenes to human hematopoietic stem cells (HSCs). This, coupled with the rising utilization of viral vectors in novel drug delivery, is positively influencing the market growth. Furthermore, the introduction of advanced therapies, the rising number of gene therapy-based research and development (R&D) activities, and the increasing manufacturing capacities of key players are anticipated to propel the market growth. Looking forward, IMARC Group expects the market value to reach US$ 3,162.5 Million by 2027, exhibiting a CAGR of 25.40% during the forecast period (2022-2027).

Market Summary:

  • Based on the type, the market has been segmented into adenoviral, adeno-associated, lentiviral, retroviral, and other viral vectors.
  • On the basis of the disease, the market has been classified into cancer, genetic disorders, infectious diseases, and others.
  • Based on the application, the market has been bifurcated into gene therapy and vaccinology.
  • On the basis of the end user, the market has been categorized into pharmaceutical and biopharmaceutical companies, and research institutes.
  • Region-wise, the market has been divided into North America (the United States and Canada), Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others), Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others), Latin America (Brazil, Mexico, and others), and Middle East and Africa.
  • The competitive landscape of the industry has also been examined, with some of the key players being Cognate BioServices Inc. (Charles River Laboratories International Inc.), F. Hoffmann-La Roche AG, FinVector Oy, FUJIFILM Holdings Corporation, Kaneka Eurogentec S.A. (Kaneka Corporation), Lonza Group AG, Merck KGaA, Oxford Biomedica plc, REGENXBIO Inc., Sanofi S.A., Thermo Fisher Scientific Inc. and uniQure N.V.


About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Global Viral Vector Manufacturing Market to Reach US$ 3,162.5 Million by 2027, Bolstered by Increasing Number of Cancer Patients
Select Licence Type



Benefits of Customization

Personalize This Research

Triangulate with your Data

Get Data as per your Format and Definition

Gain a Deeper Dive into a Specific Application, Geography, Customer or Competitor

Any level of Personalization

Get in Touch With Us
UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-713-2163

Email: sales@imarcgroup.com

Client Testimonials

Aktive Services

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

Read More
Bayer AH

It was indeed a great experience to work with IMARC on the assignment on Aqua market. The team had done a fantastic job in terms of what was expected, what was assured and what was the result… the report gave us many insights and market know how which allowed us to work on our strength and define exact strategies…

Read More
Colruyt Group

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Read More
KRISHAK BHARTI CO-OP LTD

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

Read More
Zee Media Corp. Ltd.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Read More
Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

Read More
Sumitomo Corporation

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

Read More
Hameln Rds

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

Read More
Quality Consultants BV

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

Read More
TATA Advanced Systems Limited

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

Read More
Stax

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

Read More